In our leiomyosarcoma cases, clinical stage of the group with high-BDNF/TrkB was stage I (n = 1) and stage IV (n = 2), whereas low-BDNF/TrkB group was stage I (n = 2) and stage IV (n = 2). This evidence concerns the gene BDNF and leiomyosarcoma.